Industry Research Reports

Home > Reports > Pharma & Healthcare > Anticancer Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Anticancer Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Pharma & Healthcare

Published: 2024-01-24

Pages: 119 Pages

Report ld: 2331714

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

Anticancer drugs are medications used to treat cancer by targeting and killing cancer cells or inhibiting their growth.

The global market for Anticancer Drugs was estimated to be worth US$ 85000 million in 2023 and is forecast to a readjusted size of US$ 112910 million by 2030 with a CAGR of 3.7% during the forecast period 2024-2030

Anticancer Drugs Market Size

M= millions and B=billions

The market for anticancer drugs is driven by the increasing incidence of cancer and the growing demand for effective and personalized cancer treatments. The development of targeted and immunotherapeutic drugs further boosts the market growth.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Anticancer Drugs, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Anticancer Drugs by region & country, by Type, and by Application.

The Anticancer Drugs market size, estimations, and forecasts are provided in terms of sales volume (MT) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anticancer Drugs.

Market Segmentation

Report Metric
Details
Report Title
Anticancer Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Forecasted Market Size in 2030
US$ 112910 million
CAGR(2024-2030)
3.7%
Market Size Available for Years
2019-2030
Global Anticancer Drugs Companies Covered
F. Hoffmann-La Roche Ltd, Eli Lilly and Company, CELGENE CORPORATION, Novartis AG, Pfizer Inc, Amgen Inc, Bayer AG, AstraZeneca, Takeda Pharmaceutical Company Limited, Merck & Co.
Global Anticancer Drugs Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Anticancer Drugs Market, Segment by Type
Cytotoxic Drugs (Alkylating Agents, and Antimetabolites)

Targeted Drugs (Monoclonal Antibodies and Tyrosine Kinase Inhibitors)

Hormonal Drugs
Global Anticancer Drugs Market, Segment by Application
Lung Cancer

Breast Cancer

Leukemia

Colorectal Cancer

Other
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Anticancer Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Anticancer Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Anticancer Drugs in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 Anticancer Drugs Product Introduction
    1.2 Global Anticancer Drugs Market Size Forecast
        1.2.1 Global Anticancer Drugs Sales Value (2019-2030)
        1.2.2 Global Anticancer Drugs Sales Volume (2019-2030)
        1.2.3 Global Anticancer Drugs Sales Price (2019-2030)
    1.3 Anticancer Drugs Market Trends & Drivers
        1.3.1 Anticancer Drugs Industry Trends
        1.3.2 Anticancer Drugs Market Drivers & Opportunity
        1.3.3 Anticancer Drugs Market Challenges
        1.3.4 Anticancer Drugs Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Anticancer Drugs Players Revenue Ranking (2023)
    2.2 Global Anticancer Drugs Revenue by Company (2019-2024)
    2.3 Global Anticancer Drugs Players Sales Volume Ranking (2023)
    2.4 Global Anticancer Drugs Sales Volume by Company Players (2019-2024)
    2.5 Global Anticancer Drugs Average Price by Company (2019-2024)
    2.6 Key Manufacturers Anticancer Drugs Manufacturing Base Distribution and Headquarters
    2.7 Key Manufacturers Anticancer Drugs Product Offered
    2.8 Key Manufacturers Time to Begin Mass Production of Anticancer Drugs
    2.9 Anticancer Drugs Market Competitive Analysis
        2.9.1 Anticancer Drugs Market Concentration Rate (2019-2024)
        2.9.2 Global 5 and 10 Largest Manufacturers by Anticancer Drugs Revenue in 2023
        2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anticancer Drugs as of 2023)
    2.10 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Cytotoxic Drugs (Alkylating Agents, and Antimetabolites)
        3.1.2 Targeted Drugs (Monoclonal Antibodies and Tyrosine Kinase Inhibitors)
        3.1.3 Hormonal Drugs
    3.2 Global Anticancer Drugs Sales Value by Type
        3.2.1 Global Anticancer Drugs Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Anticancer Drugs Sales Value, by Type (2019-2030)
        3.2.3 Global Anticancer Drugs Sales Value, by Type (%) (2019-2030)
    3.3 Global Anticancer Drugs Sales Volume by Type
        3.3.1 Global Anticancer Drugs Sales Volume by Type (2019 VS 2023 VS 2030)
        3.3.2 Global Anticancer Drugs Sales Volume, by Type (2019-2030)
        3.3.3 Global Anticancer Drugs Sales Volume, by Type (%) (2019-2030)
    3.4 Global Anticancer Drugs Average Price by Type (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Lung Cancer
        4.1.2 Breast Cancer
        4.1.3 Leukemia
        4.1.4 Colorectal Cancer
        4.1.5 Other
    4.2 Global Anticancer Drugs Sales Value by Application
        4.2.1 Global Anticancer Drugs Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Anticancer Drugs Sales Value, by Application (2019-2030)
        4.2.3 Global Anticancer Drugs Sales Value, by Application (%) (2019-2030)
    4.3 Global Anticancer Drugs Sales Volume by Application
        4.3.1 Global Anticancer Drugs Sales Volume by Application (2019 VS 2023 VS 2030)
        4.3.2 Global Anticancer Drugs Sales Volume, by Application (2019-2030)
        4.3.3 Global Anticancer Drugs Sales Volume, by Application (%) (2019-2030)
    4.4 Global Anticancer Drugs Average Price by Application (2019-2030)

 5 Segmentation by Region
    5.1 Global Anticancer Drugs Sales Value by Region
        5.1.1 Global Anticancer Drugs Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Anticancer Drugs Sales Value by Region (2019-2024)
        5.1.3 Global Anticancer Drugs Sales Value by Region (2025-2030)
        5.1.4 Global Anticancer Drugs Sales Value by Region (%), (2019-2030)
    5.2 Global Anticancer Drugs Sales Volume by Region
        5.2.1 Global Anticancer Drugs Sales Volume by Region: 2019 VS 2023 VS 2030
        5.2.2 Global Anticancer Drugs Sales Volume by Region (2019-2024)
        5.2.3 Global Anticancer Drugs Sales Volume by Region (2025-2030)
        5.2.4 Global Anticancer Drugs Sales Volume by Region (%), (2019-2030)
    5.3 Global Anticancer Drugs Average Price by Region (2019-2030)
    5.4 North America
        5.4.1 North America Anticancer Drugs Sales Value, 2019-2030
        5.4.2 North America Anticancer Drugs Sales Value by Country (%), 2023 VS 2030
    5.5 Europe
        5.5.1 Europe Anticancer Drugs Sales Value, 2019-2030
        5.5.2 Europe Anticancer Drugs Sales Value by Country (%), 2023 VS 2030
    5.6 Asia Pacific
        5.6.1 Asia Pacific Anticancer Drugs Sales Value, 2019-2030
        5.6.2 Asia Pacific Anticancer Drugs Sales Value by Country (%), 2023 VS 2030
    5.7 South America
        5.7.1 South America Anticancer Drugs Sales Value, 2019-2030
        5.7.2 South America Anticancer Drugs Sales Value by Country (%), 2023 VS 2030
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa Anticancer Drugs Sales Value, 2019-2030
        5.8.2 Middle East & Africa Anticancer Drugs Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Anticancer Drugs Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Anticancer Drugs Sales Value
        6.2.1 Key Countries/Regions Anticancer Drugs Sales Value, 2019-2030
        6.2.2 Key Countries/Regions Anticancer Drugs Sales Volume, 2019-2030
    6.3 United States
        6.3.1 United States Anticancer Drugs Sales Value, 2019-2030
        6.3.2 United States Anticancer Drugs Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Anticancer Drugs Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Anticancer Drugs Sales Value, 2019-2030
        6.4.2 Europe Anticancer Drugs Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Anticancer Drugs Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Anticancer Drugs Sales Value, 2019-2030
        6.5.2 China Anticancer Drugs Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Anticancer Drugs Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Anticancer Drugs Sales Value, 2019-2030
        6.6.2 Japan Anticancer Drugs Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Anticancer Drugs Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Anticancer Drugs Sales Value, 2019-2030
        6.7.2 South Korea Anticancer Drugs Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Anticancer Drugs Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Anticancer Drugs Sales Value, 2019-2030
        6.8.2 Southeast Asia Anticancer Drugs Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Anticancer Drugs Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Anticancer Drugs Sales Value, 2019-2030
        6.9.2 India Anticancer Drugs Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Anticancer Drugs Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 F. Hoffmann-La Roche Ltd
        7.1.1 F. Hoffmann-La Roche Ltd Company Information
        7.1.2 F. Hoffmann-La Roche Ltd Introduction and Business Overview
        7.1.3 F. Hoffmann-La Roche Ltd Anticancer Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.1.4 F. Hoffmann-La Roche Ltd Anticancer Drugs Product Offerings
        7.1.5 F. Hoffmann-La Roche Ltd Recent Development
    7.2 Eli Lilly and Company
        7.2.1 Eli Lilly and Company Company Information
        7.2.2 Eli Lilly and Company Introduction and Business Overview
        7.2.3 Eli Lilly and Company Anticancer Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.2.4 Eli Lilly and Company Anticancer Drugs Product Offerings
        7.2.5 Eli Lilly and Company Recent Development
    7.3 CELGENE CORPORATION
        7.3.1 CELGENE CORPORATION Company Information
        7.3.2 CELGENE CORPORATION Introduction and Business Overview
        7.3.3 CELGENE CORPORATION Anticancer Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.3.4 CELGENE CORPORATION Anticancer Drugs Product Offerings
        7.3.5 CELGENE CORPORATION Recent Development
    7.4 Novartis AG
        7.4.1 Novartis AG Company Information
        7.4.2 Novartis AG Introduction and Business Overview
        7.4.3 Novartis AG Anticancer Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.4.4 Novartis AG Anticancer Drugs Product Offerings
        7.4.5 Novartis AG Recent Development
    7.5 Pfizer Inc
        7.5.1 Pfizer Inc Company Information
        7.5.2 Pfizer Inc Introduction and Business Overview
        7.5.3 Pfizer Inc Anticancer Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.5.4 Pfizer Inc Anticancer Drugs Product Offerings
        7.5.5 Pfizer Inc Recent Development
    7.6 Amgen Inc
        7.6.1 Amgen Inc Company Information
        7.6.2 Amgen Inc Introduction and Business Overview
        7.6.3 Amgen Inc Anticancer Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.6.4 Amgen Inc Anticancer Drugs Product Offerings
        7.6.5 Amgen Inc Recent Development
    7.7 Bayer AG
        7.7.1 Bayer AG Company Information
        7.7.2 Bayer AG Introduction and Business Overview
        7.7.3 Bayer AG Anticancer Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.7.4 Bayer AG Anticancer Drugs Product Offerings
        7.7.5 Bayer AG Recent Development
    7.8 AstraZeneca
        7.8.1 AstraZeneca Company Information
        7.8.2 AstraZeneca Introduction and Business Overview
        7.8.3 AstraZeneca Anticancer Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.8.4 AstraZeneca Anticancer Drugs Product Offerings
        7.8.5 AstraZeneca Recent Development
    7.9 Takeda Pharmaceutical Company Limited
        7.9.1 Takeda Pharmaceutical Company Limited Company Information
        7.9.2 Takeda Pharmaceutical Company Limited Introduction and Business Overview
        7.9.3 Takeda Pharmaceutical Company Limited Anticancer Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.9.4 Takeda Pharmaceutical Company Limited Anticancer Drugs Product Offerings
        7.9.5 Takeda Pharmaceutical Company Limited Recent Development
    7.10 Merck & Co.
        7.10.1 Merck & Co. Company Information
        7.10.2 Merck & Co. Introduction and Business Overview
        7.10.3 Merck & Co. Anticancer Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.10.4 Merck & Co. Anticancer Drugs Product Offerings
        7.10.5 Merck & Co. Recent Development

 8 Industry Chain Analysis
    8.1 Anticancer Drugs Industrial Chain
    8.2 Anticancer Drugs Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Anticancer Drugs Sales Model
        8.5.2 Sales Channel
        8.5.3 Anticancer Drugs Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Anticancer Drugs Market Trends
    Table 2. Anticancer Drugs Market Drivers & Opportunity
    Table 3. Anticancer Drugs Market Challenges
    Table 4. Anticancer Drugs Market Restraints
    Table 5. Global Anticancer Drugs Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Anticancer Drugs Revenue Market Share by Company (2019-2024)
    Table 7. Global Anticancer Drugs Sales Volume by Company (2019-2024) & (MT)
    Table 8. Global Anticancer Drugs Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Anticancer Drugs Price by Company (2019-2024) & (USD/Kg)
    Table 10. Key Manufacturers Anticancer Drugs Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Anticancer Drugs Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Anticancer Drugs
    Table 13. Global Anticancer Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anticancer Drugs as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Anticancer Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Anticancer Drugs Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Anticancer Drugs Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Anticancer Drugs Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Anticancer Drugs Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Anticancer Drugs Sales Volume by Type: 2019 VS 2023 VS 2030 (MT)
    Table 22. Global Anticancer Drugs Sales Volume by Type (2019-2024) & (MT)
    Table 23. Global Anticancer Drugs Sales Volume by Type (2025-2030) & (MT)
    Table 24. Global Anticancer Drugs Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Anticancer Drugs Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Anticancer Drugs Price by Type (2019-2024) & (USD/Kg)
    Table 27. Global Anticancer Drugs Price by Type (2025-2030) & (USD/Kg)
    Table 28. Global Anticancer Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Anticancer Drugs Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Anticancer Drugs Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Anticancer Drugs Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Anticancer Drugs Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Anticancer Drugs Sales Volume by Application: 2019 VS 2023 VS 2030 (MT)
    Table 34. Global Anticancer Drugs Sales Volume by Application (2019-2024) & (MT)
    Table 35. Global Anticancer Drugs Sales Volume by Application (2025-2030) & (MT)
    Table 36. Global Anticancer Drugs Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Anticancer Drugs Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Anticancer Drugs Price by Application (2019-2024) & (USD/Kg)
    Table 39. Global Anticancer Drugs Price by Application (2025-2030) & (USD/Kg)
    Table 40. Global Anticancer Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Anticancer Drugs Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Anticancer Drugs Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Anticancer Drugs Sales Value by Region (2019-2024) & (%)
    Table 44. Global Anticancer Drugs Sales Value by Region (2025-2030) & (%)
    Table 45. Global Anticancer Drugs Sales Volume by Region (MT): 2019 VS 2023 VS 2030
    Table 46. Global Anticancer Drugs Sales Volume by Region (2019-2024) & (MT)
    Table 47. Global Anticancer Drugs Sales Volume by Region (2025-2030) & (MT)
    Table 48. Global Anticancer Drugs Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Anticancer Drugs Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Anticancer Drugs Average Price by Region (2019-2024) & (USD/Kg)
    Table 51. Global Anticancer Drugs Average Price by Region (2025-2030) & (USD/Kg)
    Table 52. Key Countries/Regions Anticancer Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Anticancer Drugs Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Anticancer Drugs Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Anticancer Drugs Sales Volume, (2019-2024) & (MT)
    Table 56. Key Countries/Regions Anticancer Drugs Sales Volume, (2025-2030) & (MT)
    Table 57. F. Hoffmann-La Roche Ltd Company Information
    Table 58. F. Hoffmann-La Roche Ltd Introduction and Business Overview
    Table 59. F. Hoffmann-La Roche Ltd Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 60. F. Hoffmann-La Roche Ltd Anticancer Drugs Product Offerings
    Table 61. F. Hoffmann-La Roche Ltd Recent Development
    Table 62. Eli Lilly and Company Company Information
    Table 63. Eli Lilly and Company Introduction and Business Overview
    Table 64. Eli Lilly and Company Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 65. Eli Lilly and Company Anticancer Drugs Product Offerings
    Table 66. Eli Lilly and Company Recent Development
    Table 67. CELGENE CORPORATION Company Information
    Table 68. CELGENE CORPORATION Introduction and Business Overview
    Table 69. CELGENE CORPORATION Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 70. CELGENE CORPORATION Anticancer Drugs Product Offerings
    Table 71. CELGENE CORPORATION Recent Development
    Table 72. Novartis AG Company Information
    Table 73. Novartis AG Introduction and Business Overview
    Table 74. Novartis AG Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 75. Novartis AG Anticancer Drugs Product Offerings
    Table 76. Novartis AG Recent Development
    Table 77. Pfizer Inc Company Information
    Table 78. Pfizer Inc Introduction and Business Overview
    Table 79. Pfizer Inc Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 80. Pfizer Inc Anticancer Drugs Product Offerings
    Table 81. Pfizer Inc Recent Development
    Table 82. Amgen Inc Company Information
    Table 83. Amgen Inc Introduction and Business Overview
    Table 84. Amgen Inc Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 85. Amgen Inc Anticancer Drugs Product Offerings
    Table 86. Amgen Inc Recent Development
    Table 87. Bayer AG Company Information
    Table 88. Bayer AG Introduction and Business Overview
    Table 89. Bayer AG Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 90. Bayer AG Anticancer Drugs Product Offerings
    Table 91. Bayer AG Recent Development
    Table 92. AstraZeneca Company Information
    Table 93. AstraZeneca Introduction and Business Overview
    Table 94. AstraZeneca Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 95. AstraZeneca Anticancer Drugs Product Offerings
    Table 96. AstraZeneca Recent Development
    Table 97. Takeda Pharmaceutical Company Limited Company Information
    Table 98. Takeda Pharmaceutical Company Limited Introduction and Business Overview
    Table 99. Takeda Pharmaceutical Company Limited Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 100. Takeda Pharmaceutical Company Limited Anticancer Drugs Product Offerings
    Table 101. Takeda Pharmaceutical Company Limited Recent Development
    Table 102. Merck & Co. Company Information
    Table 103. Merck & Co. Introduction and Business Overview
    Table 104. Merck & Co. Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 105. Merck & Co. Anticancer Drugs Product Offerings
    Table 106. Merck & Co. Recent Development
    Table 107. Key Raw Materials Lists
    Table 108. Raw Materials Key Suppliers Lists
    Table 109. Anticancer Drugs Downstream Customers
    Table 110. Anticancer Drugs Distributors List
    Table 111. Research Programs/Design for This Report
    Table 112. Key Data Information from Secondary Sources
    Table 113. Key Data Information from Primary Sources
List of Figures
    Figure 1. Anticancer Drugs Product Picture
    Figure 2. Global Anticancer Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Anticancer Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Anticancer Drugs Sales Volume (2019-2030) & (MT)
    Figure 5. Global Anticancer Drugs Sales Price (2019-2030) & (USD/Kg)
    Figure 6. Anticancer Drugs Report Years Considered
    Figure 7. Global Anticancer Drugs Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Anticancer Drugs Players Sales Volume Ranking (2023) & (MT)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Anticancer Drugs Revenue in 2023
    Figure 10. Anticancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Cytotoxic Drugs (Alkylating Agents, and Antimetabolites) Picture
    Figure 12. Targeted Drugs (Monoclonal Antibodies and Tyrosine Kinase Inhibitors) Picture
    Figure 13. Hormonal Drugs Picture
    Figure 14. Global Anticancer Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 15. Global Anticancer Drugs Sales Value Market Share by Type, 2023 & 2030
    Figure 16. Global Anticancer Drugs Sales Volume by Type (2019 VS 2023 VS 2030) & (MT)
    Figure 17. Global Anticancer Drugs Sales Volume Market Share by Type, 2023 & 2030
    Figure 18. Global Anticancer Drugs Price by Type (2019-2030) & (USD/Kg)
    Figure 19. Product Picture of Lung Cancer
    Figure 20. Product Picture of Breast Cancer
    Figure 21. Product Picture of Leukemia
    Figure 22. Product Picture of Colorectal Cancer
    Figure 23. Product Picture of Other
    Figure 24. Global Anticancer Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 25. Global Anticancer Drugs Sales Value Market Share by Application, 2023 & 2030
    Figure 26. Global Anticancer Drugs Sales Volume by Application (2019 VS 2023 VS 2030) & (MT)
    Figure 27. Global Anticancer Drugs Sales Volume Market Share by Application, 2023 & 2030
    Figure 28. Global Anticancer Drugs Price by Application (2019-2030) & (USD/Kg)
    Figure 29. North America Anticancer Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 30. North America Anticancer Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 31. Europe Anticancer Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 32. Europe Anticancer Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 33. Asia Pacific Anticancer Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 34. Asia Pacific Anticancer Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 35. South America Anticancer Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 36. South America Anticancer Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 37. Middle East & Africa Anticancer Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 38. Middle East & Africa Anticancer Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 39. Key Countries/Regions Anticancer Drugs Sales Value (%), (2019-2030)
    Figure 40. Key Countries/Regions Anticancer Drugs Sales Volume (%), (2019-2030)
    Figure 41. United States Anticancer Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 42. United States Anticancer Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 43. United States Anticancer Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 44. Europe Anticancer Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 45. Europe Anticancer Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 46. Europe Anticancer Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 47. China Anticancer Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 48. China Anticancer Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 49. China Anticancer Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 50. Japan Anticancer Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 51. Japan Anticancer Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 52. Japan Anticancer Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 53. South Korea Anticancer Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 54. South Korea Anticancer Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 55. South Korea Anticancer Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 56. Southeast Asia Anticancer Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 57. Southeast Asia Anticancer Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 58. Southeast Asia Anticancer Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 59. India Anticancer Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 60. India Anticancer Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 61. India Anticancer Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 62. Anticancer Drugs Industrial Chain
    Figure 63. Anticancer Drugs Manufacturing Cost Structure
    Figure 64. Channels of Distribution (Direct Sales, and Distribution)
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed

Description

Anticancer drugs are medications used to treat cancer by targeting and killing cancer cells or inhibiting their growth.

The global market for Anticancer Drugs was estimated to be worth US$ 85000 million in 2023 and is forecast to a readjusted size of US$ 112910 million by 2030 with a CAGR of 3.7% during the forecast period 2024-2030

The market for anticancer drugs is driven by the increasing incidence of cancer and the growing demand for effective and personalized cancer treatments. The development of targeted and immunotherapeutic drugs further boosts the market growth.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Anticancer Drugs, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Anticancer Drugs by region & country, by Type, and by Application.

The Anticancer Drugs market size, estimations, and forecasts are provided in terms of sales volume (MT) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anticancer Drugs.

Market Segmentation